CEOs Against Cancer - Florida Chapter的动态

17 years ago I joined the now named #Generations study for breast cancer research . My mum , sister and I and some of my friends send blood samples , questionnaires and results of screenings . Over 100,000 women took part in the last 20 years and the findings include : - the discovery of genetic risk factors - reproductive history and risk - body weight and risk - physical activity and risk I am really interested to see what happens in the next 5 years, particularly in the use of AI analyses of breast tissue . If you get the opportunity to take part in research like this - please do ?? #WorldCancerResearchDay

This weekend, the American Society of Clinical Oncology (ASCO) conference showcased ground-breaking advancements in the treatment of leukaemia and other haematological malignancies as well as a host of other cancers. A pivotal Phase 3 trial (the ASC4FIRST study) was presented, comparing the first in class drug asciminib with other tyrosine kinase inhibitors (TKIs) in newly diagnosed chronic myeloid leukaemia (CML) patients. The promising results provide evidence that asciminib could become potentially become a first-line treatment in CML, although longer- term follow up data will be needed first. Currently asciminib is available to certain CML patients if other two or more other TKIs have been tried first. Additionally, significant progress was showcased at ASCO in hematopoietic stem cell transplants. A Phase 1 study of STC-15, a METTL-3 inhibitor, showed encouraging results in patients with advanced malignancies, demonstrating safety and clinical activity. This lays the groundwork for Phase 2 trials later this year. Leukaemia UK has funded Dr Kostas Tzelepis's laboratory research at Cambridge on targeting METTL-3 in leukaemia in collaboration with STORM Therapeutics, which led this new trial. We are proud to support such pioneering laboratory work, which could help to underpin the development of potential new leukaemia treatments. https://lnkd.in/eQ3n8GnS #ASCO2024 #LeukemiaResearch #Oncology #Hematology #CancerTreatment #ClinicalTrials #InnovationInHealthcare

Cancer researchers around the world work tirelessly, fueled by hope, innovation, and resilience. Each discovery, each breakthrough brings us closer to a future where cancer is not a threat, but a conquerable challenge. From unraveling the mysteries of cancer metabolism to pioneering personalized therapies, the collective efforts of scientists, clinicians, and collaborators are transforming the fight against this disease. Together, we stand united in our ultimate goal: to defeat all cancers. #CancerResearch #ScienceForHope #DefeatCancer

The American Society of Clinical Oncology (ASCO) Annual Meeting is an important event in the oncology field, bringing together top researchers, trialists and clinicians to discuss groundbreaking cancer research and innovative therapies. Held from May 31 to June 4, 2024, in Chicago, this year’s meeting continues to highlight significant advancements, with respect to newer therapies and newer approaches in cancer care. Whether it was newer therapies, the use of previously unused combinations or investigative approaches like ctDNA, it had’em all. However, it’s crucial to make such influential events more accessible to professionals from low to middle-income countries (LMICs). Providing scholarships, virtual attendance options, and enhanced partnerships can bridge the gap, ensuring broader participation and fostering global collaboration in the fight against cancer. By expanding opportunities for all, we can drive forward the mission of health for all. #ASCO2024 #Oncology #CancerResearch #GlobalHealth

In our latest article, learn how leading-edge, multidisciplinary approaches transform childhood cancer research and care. Dive into the insights here: ?? https://buff.ly/3yBEXxL #ChildhoodCancer #wearecbtn #togetherwerise

Cancer is the one opponent that unites the entire Big Ten Conference, and this video underscores our commitment to transforming cancer research and improving lives. Check it out! https://ow.ly/ZtKf50RzToW #BIGTENvsCancer

?? Meet Tom in the latest video in our #MeetOurTeam series! Check out the video to learn more about Tom and the work he does in our marketing team to help raise awareness and support our mission. ?? Stay tuned for more team highlights! ??

Learn emerging strategies and best practices to advance patient-centered, evidence-based collaborative cardiovascular and cancer care for patients living with and beyond cancer at ACC #CardioOnc 2025. The sessions include: ?? Register before Jan. 14 and SAVE: https://bit.ly/4hbM3Ke

The Global Patient Survey is a tool for change! Your feedback helps doctors and researchers understand what matters most to #KidneyCancer patients. Share your experience and help make a difference for the global kidney cancer community. Survey link: https://bit.ly/IKCCSurvey #AcceleratingCures

Why give monthly to Conquer Cancer? Monthly gifts help fund vital programs and breakthrough research that create advancements in cancer care year-round. Learn more at CONQUER.ORG.